Related Experiment Video
Updated: Jul 2, 2026

Induction of Acute Skeletal Muscle Regeneration by Cardiotoxin Injection
Published on: January 1, 2017
Herba Epimedium (Horny Goat Weed) Toxicity With Severe Muscle Spasms and Elevated Creatine Kinase and Creatinine: A
Tucker Ledo1, Dhara Patel1, Wayne Tamaska1
1Emergency Medicine, Jefferson Health, Stratford, USA.
Abstract:
Here, we present the case of a 33-year-old man who presented to the emergency department (ED) with a complaint of severe muscle spasms of a 10-hour duration. He noted that he took a supplement which he purchased over the internet called Epimedium, also known as horny goat weed, for the purpose of improving his mood and sense of energy and reducing his sense of anxiety. He started this supplement one month prior to ED presentation, coincident with the first episodes of muscle cramps. In the ED, he had elevations of his creatine kinase (CK) and creatinine and required hospital admission. His creatinine and CK elevations and muscle spasms improved during his hospital admission. He was discharged from the hospital with instructions to stop taking Epimedium supplements. Epimedium contains a wide variety of chemicals that vary somewhat by individual species. To our knowledge, this is the first specific case report of severe muscle spasms with associated elevations of CK and creatinine caused by Epimedium use. This case reinforces the importance of asking a patient about all medications, including over-the-internet, over-the-counter, and herbal medications.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Heart Failure Drugs: Inotropic Agents
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Myocarditis III: Medical Management

